Category: Other Industry

340B Providers Blindsided by Bausch Health’s Decision to Drop AmerisourceBergen as Distributor

In Federal, Other Industry, Pharma Industry, RegulatoryJanuary 12, 202162 Views

340B covered entities are scrambling to respond to the fallout from Bausch Health's surprise announcement that it ended its relationship with AmerisourceBergen to distribute its 340B-priced branded products. | Source: Shutterstock

Drug manufacturer Bausch Health blindsided 340B covered entities on New Year’s Eve, announcing that starting the very next day, Jan. 1, more than 200 of its branded products and future branded products would no longer be available through distributor AmerisourceBergen …

Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021

In Federal, Other Industry, Pharma Industry, RegulatoryDecember 17, 202019 Views

Tom Mirga

Drug manufacturer reimbursement vendor Kalderos expects “a number of manufacturers” will begin using its 340B Pay software platform during the first quarter of 2021, the company told 340B Report last night. “We are fielding a high level of interest from …

The New York Times, Often a Public Policy Shaper, Runs Article on 340B Pricing Denials

In Federal, Other Industry, Pharma Industry, RegulatoryDecember 16, 202014 Views

Tom Mirga

The New York Times has published a news article about “top pharmaceutical companies [that] have stopped giving federally mandated drug discounts to hospitals and clinics that care for the poorest Americans,” and the bipartisan pressure building on outgoing U.S. Health …

Providers Are Pleased, PhRMA Isn’t, With Becerra and State AGs’ 340B Letter to Azar

In Federal, Other Industry, Pharma Industry, Regulatory, State, Trade Association, UncategorizedDecember 15, 20207 Views

Tom Mirga

Health care providers are applauding a bipartisan group of 29 state attorneys general (including the District of Columbia’s) for their letter yesterday to HHS Secretary Alex Azar urging him “to address drug manufacturers’ unlawful refusal to provide critical drug discounts …

BREAKING: Bipartisan Group of 217 U.S. Representatives Ask HHS to Stop 340B Rebate Model and Look Into Third Party Vendors

In Breaking, Federal, Legislative, Other Industry, Pharma Industry, RegulatoryNovember 13, 202016 Views

Tom Mirga

Two hundred seventeen U.S. representatives—173 Democrats and 44 Republicans—this morning asked U.S. Health and Human Services (HHS) Secretary Alex Azar to take immediate action to stop drug companies and a vendor from changing the 340B program from a discount to …

More than Half of Health Care Industry Execs Expect 340B Reporting Requirements Within Five Years

In Legislative, Other Industry, Pharma Industry, Regulatory, Research/ReportsOctober 8, 202013 Views

Tom Mirga

More than half (55 percent) of 130 health care industry C-suite executives surveyed expect that reporting requirements and other restrictions will be attached to the 340B program within the next five years, a health care consulting firm’s latest survey of …

Drug Store Chains Want HHS to Block Pharma’s Moves Against 340B Contract Pharmacy

In Federal, Other Industry, Pharma Industry, RegulatoryAugust 26, 202014 Views

Tom Mirga

The National Association of Chain Drug Stores (NACDS) wants the U.S. Health Resources and Services Administration (HRSA) “to take swift action to enforce the clear meaning of the 340B statute” with respect to drug manufacturers that “no longer provide 340B …

340B Supply Chain Partners Push Back Against Manufacturer Contract Pharmacy Requests

In Federal, Other Industry, Pharma Industry, RegulatoryAugust 20, 20209 Views

Tom Mirga

Business units of two of the nation’s largest health care conglomerates warned a major U.S. health system yesterday to carefully consider whether to obey drug manufacturer Merck’s request and manufacturer Sanofi’s demand to upload their 340B contract pharmacy claims data …

BREAKING: Omnicell Buys PSG’s 340B Line of Business, the Latest in a Trend of 340B TPA Acquisitions

In Breaking, Other IndustryAugust 12, 202014 Views

Tom Mirga

Omnicell Inc., a leading provider of automated drug dispensing systems and other prescription drug supply chain products and services, has agreed to buy Pharmaceutical Strategies Group’s 340B Link business, PSG’s 340B third party administrator (TPA) suite of services. (PSG is …

340B ESP Wants to Be Pharma’s Go-to on 340B Duplicate Discounts. Kalderos Says Not So Fast.

In Federal, Other Industry, Pharma IndustryJuly 16, 20206 Views

Tom Mirga

SPONSORED BY A Message from Publisher and CEO Ted Slafsky: We recently welcomed FQHC 340B Compliances Services to our growing list of sponsors. In today’s sponsored content article, FQHC 340B Lead Consultant Michael Gonzalez offers five great tips on how covered …